NASP elects Walgreens’ Mike Ellis as first president
ALEXANDRIA, Va. — The National Association of Specialty Pharmacy has named Walgreens corporate VP specialty pharmacy and infusion services as its first president, the organization said Tuesday.
Ellis previously worked as SVP specialty trade relations and contracting and pharmaceutical services for CVS Caremark, before joining Walgreens in 2011. He has more than 32 years’ experience in specialty pharmacy and infusion and also has worked at AdvancePCS, Olsten Health Services and Quantum Health Resources. Walgreens joined NASP as a founding member last year, and Ellis was elected at the NASP board of directors’ Oct. 14 meeting; he will serve a one-year term through October 2014.
"This is an exciting time for specialty pharmacy, and I’m excited to work with my colleagues on this distinguished board of directors to advance NASP’s mission and create a stronger, more unified voice for all stakeholders," Ellis said. "At Walgreens, we share eNASP’s dedication to serve the needs of patients living with complex, chronic health conditions and support the pharmacists they work with on a daily basis."
Walgreens uses an integrated, multichannel model for its specialty and infusion business, focusing on creating an optimal patient experience that supports improved health outcomes, NASP said, while also offering pipeline insights, custom reporting and clinical and utilization management programs to help payers manage costs.
"We are honored to work with Mike as our first president, guiding NASP forward as it continues to lead the specialty pharmacy industry," NASP CEO Gary Cohen said. "Walgreens is a strong supporter of our membership and industry as a whole, and we believe Mike will provide both the vision and leadership necessary to steer NASP and the specialty pharmacy industry to the next level."
Fairview Pharmacy Services adopts Mscripts mobile health platform
MINNEAPOLIS — A pharmacy chain based in Minnesota is offering a new mobile app and web portal for its retail customers under a partnership with San Francisco-based Mscripts, the chain said Tuesday.
Fairview Pharmacy Services, which runs about 30 retail pharmacies across the state and also specialty, compounding and mail-order facilities, said the new app would allow customers to scan and refill prescriptions, receive pickup and dosage reminders and locate stores and specials. Non-smartphone users will have a text-messaging option.
"Fairview Pharmacy prides itself on our neighborhood focus and medical expertise," Fairview chief information officer Marlaine Villas said. "We are committed to delivering the finest, most innovative health solutions to our customers. Our mobile pharmacy solution furthers this mission, while affording our customers the ease and convenience of using their mobile phones to manage their prescription needs and access other services across our pharmacy — whether they be in the neighborhood or across the country."
The mobile app will operate on a secure network and is integrated with McKesson’s EnterpriseRx pharmacy-management system, allowing Fairview to offer a variety of mobile communication pathways. The app will be available starting later this year, free of charge, for iPhone and Android users.
"Fairview Pharmacy is strengthening its ties to the community by expanding the mobile adherence services it provides to its patients," Mscripts CEO Mark Cullen said. "The mobile phone has become a trusted, integral part of daily lives, and Fairview is making it easier for customers to refill prescriptions and manage their health information wherever they may be."
Famy Care wins approval for generic contraceptive
SILVER SPRING, Md. — The Food and Drug Administration has approved a generic contraceptive drug made by Famy Care, agency records show.
The agency approved Famy’s levonorgestrel and ethinyl estradiol tablets in the 0.02-mg/0.1-mg strengths.
The drug is a generic version of Aviane-28, made by Teva Women’s Health, a division of Israeli drug maker Teva Pharmaceutical Industries that previously went under the name Duramed.